Location History:
- Rehovot, IL (2019)
- Tel Aviv, IL (2018 - 2020)
Company Filing History:
Years Active: 2018-2020
Title: Ayala Pollack: Innovator in Retinal and Fibrotic Disease Treatments
Introduction
Ayala Pollack is a prominent inventor based in Tel Aviv, Israel, known for her significant contributions to the field of medical treatments. With a total of three patents to her name, she has focused her research on innovative solutions for retinal degenerative diseases and fibrotic conditions.
Latest Patents
Pollack's latest patents include groundbreaking compositions and methods for the treatment of retinal degenerative diseases. One of her notable disclosures relates to compositions aimed at treating Alzheimer's Disease and ocular conditions such as age-related macular degeneration. These compositions contain effective amounts of LLMe, its hydrobromide form, or functional derivatives. Additionally, she has developed methods for treating fibrotic diseases, specifically targeting ocular pathologies associated with fibrosis, including proliferative vitreoretinopathy (PVR). This involves inhibiting the activity of activated transforming growth factor β-activated kinase 1 (TAK1) and providing pharmaceutical compositions for these treatments.
Career Highlights
Ayala Pollack has made significant strides in her career, particularly through her work at Mor Research Applications Ltd. Her innovative approaches have positioned her as a key figure in the development of therapeutic solutions for complex medical conditions.
Collaborations
Pollack collaborates with various professionals in her field, including her coworker Zeev Dvashi, who contributes to her research endeavors.
Conclusion
Ayala Pollack's work exemplifies the impact of innovation in medical treatments, particularly for retinal and fibrotic diseases. Her patents reflect a commitment to advancing healthcare solutions that address critical health challenges.